- Home
- TVRD vs HYLN Comparison
TVRD vs HYLN Comparison
Compare TVRD & HYLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- HYLN
- Stock Information
- Founded
- TVRD 2017
- HYLN 2018
- Country
- TVRD United States
- HYLN United States
- Employees
- TVRD N/A
- HYLN N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- HYLN Construction/Ag Equipment/Trucks
- Sector
- TVRD Health Care
- HYLN Consumer Discretionary
- Exchange
- TVRD Nasdaq
- HYLN Nasdaq
- Market Cap
- TVRD 246.5M
- HYLN 279.7M
- IPO Year
- TVRD N/A
- HYLN N/A
- Fundamental
- Price
- TVRD $26.91
- HYLN $1.43
- Analyst Decision
- TVRD Strong Buy
- HYLN Hold
- Analyst Count
- TVRD 4
- HYLN 1
- Target Price
- TVRD $58.50
- HYLN $2.00
- AVG Volume (30 Days)
- TVRD 92.7K
- HYLN 1.0M
- Earning Date
- TVRD 08-21-2025
- HYLN 08-05-2025
- Dividend Yield
- TVRD N/A
- HYLN N/A
- EPS Growth
- TVRD N/A
- HYLN N/A
- EPS
- TVRD N/A
- HYLN N/A
- Revenue
- TVRD N/A
- HYLN $1,998,000.00
- Revenue This Year
- TVRD N/A
- HYLN $741.55
- Revenue Next Year
- TVRD N/A
- HYLN $185.14
- P/E Ratio
- TVRD N/A
- HYLN N/A
- Revenue Growth
- TVRD N/A
- HYLN 451.93
- 52 Week Low
- TVRD $8.13
- HYLN $1.11
- 52 Week High
- TVRD $34.31
- HYLN $4.10
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- HYLN 52.68
- Support Level
- TVRD N/A
- HYLN $1.35
- Resistance Level
- TVRD N/A
- HYLN $1.45
- Average True Range (ATR)
- TVRD 0.00
- HYLN 0.09
- MACD
- TVRD 0.00
- HYLN 0.01
- Stochastic Oscillator
- TVRD 0.00
- HYLN 81.40
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About HYLN Hyliion Holdings Corp.
Hyliion Holdings Corp provides solutions that enable clean, flexible, and affordable electricity production. The Company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. It is initially targeting the commercial and waste management industries with a locally deployable generator that can offer prime power as well as energy arbitrage opportunities. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies.